4-Antibody AG ^Company

4-Antibody AG is a Swiss company that specializes in developing human antibody drug-discovery platforms for immuno-oncology. The company's Retrocyte Display technology platform generates therapeutic antibody drug candidates that incorporate human antibody libraries expressed in mammalian B-lineage lymphocytes. Additionally, the company develops preclinical checkpoint antibody programs targeting GITR, OX40, CTLA-4, PD-1, TIM-3, and LAG-3. The company was founded in 2002 and is based in Basel, Switzerland. Their mission is to bring affordable, curative therapies to cancer patients by leveraging the power of the immune system.